In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sichuan Kelun Pharmaceutical Co Ltd.

https://en.kelun.com/

Latest From Sichuan Kelun Pharmaceutical Co Ltd.

Paradox Of China Biotech And What Lies Ahead In 2023

The hard going could get even tougher as a funding crunch continues for China’s biotech sector, which is being hit by a paradox that could see more pain ahead, leading investors to take the pulse of the sector as the Year of the Rabbit starts.

China Scrip Perspectives

In Vivo’s Deals Of The Year: Cast Your Vote!

It is time for In Vivo's 15th annual Deals of the Year contest. We've selected 15 nominees across three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.

Deals Financing

Latest Big Rounds Herald A China Biotech Funding Spring?

Around the turn of the year, four Chinese biotechs including Kelun Biotech and BioRay ramped up funding with deals worth more than $100m, at a time when overall investment sentiment in the sector remains gloomy.

China Financing

Big Antibody Deals Offer Hope Amid Challenging Times For China Biotech

Recent antibody mega-deals are providing a rare bright spot for the embattled China biotech sector, amid sharply rising COVID-19 deaths in the country that indicate rebound and recovery could take longer than previously expected.

China Coronavirus COVID-19
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • Vaccines
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Guangxi Kelun Pharmaceutical Co Ltd
    • Hunan Kelun Pharmaceutical Co Ltd
    • Hubei Kelun Pharmaceutical Co Ltd
    • Kelun Pharmaceutical Group
    • KLUS Pharma Inc
    • Shandong Kelun Pharmaceutical Co Ltd
    • Sichuan Kelun Pharmaceutical Research Co Ltd
    • Suzhou Kelun Pharmaceutical Research Co Ltd
    • Sichuan Xindi Pharmaceutical Chemicals Co Ltd
UsernamePublicRestriction

Register